Breast Cancer
Breast Cancer is a type of cancer that forms in the cells of the breasts, and it can affect both men and women. Symptoms may include a lump in the breast, changes in breast shape or size, and unusual discharge from the nipple.
Breast MRI: Low-Dose Gadolinium Study
We are testing whether a lower dose of gadolinium in breast MRI can provide image quality similar to the standard dose. This may help reduce contrast exposure while maintaining diagnostic accuracy.
1-2 yearsConfirmation phase (III)Monitoring phase (IV)No PlaceboInvestigational MedicinesInjectionInternal MedicineOncologyOtolaryngology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman over 18 years old?
- Are you scheduled to undergo a contrast-enhanced breast MRI?
- Are you pregnant or breastfeeding?
- Do you have any metal implants or a pacemaker that would prevent you from having an MRI?
- Do you have kidney problems, such as an eGFR less than 30?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Dotarem
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Radboud universitair medisch centrum Stichting
Radiology and Nuclear Medicine
Nijmegen, Netherlands
Sponsor: Radboud universitair medisch centrum Stichting
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.